FRI0145 The effect of adalimumab on risk of major adverse cardiovascular events in rheumatoid arthritis: A meta-analysis of randomized trials

Background Patients with rheumatoid arthritis (RA) have greater cardiovascular (CV) morbidity compared with the general population. Blockade of the pro-inflammatory cytokine tumor necrosis factor-α (TNF) by anti-TNF therapies has been hypothesized to reduce CV risk, and use of these agents has been...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.359-360
Hauptverfasser:	Burmester, G., Emery, P., Signorovitch, J., Williams, D., Valdes, J., Bao, Y., Mulani, P.M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!